OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Perspectives on anti-IL-1 inhibitors as potential therapeutic interventions for severe COVID-19
Jie Geng, Feng Wang, Zhiwei Huang, et al.
Cytokine (2021) Vol. 143, pp. 155544-155544
Open Access | Times Cited: 25
Jie Geng, Feng Wang, Zhiwei Huang, et al.
Cytokine (2021) Vol. 143, pp. 155544-155544
Open Access | Times Cited: 25
Showing 25 citing articles:
Understanding Autoimmunity: Mechanisms, Predisposing Factors, and Cytokine Therapies
Farzana Yasmeen, Rameez Hassan Pirzada, Bilal Ahmad, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7666-7666
Open Access | Times Cited: 14
Farzana Yasmeen, Rameez Hassan Pirzada, Bilal Ahmad, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7666-7666
Open Access | Times Cited: 14
Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions
Yujie Jiang, Tingmei Zhao, Xueyan Zhou, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 42
Yujie Jiang, Tingmei Zhao, Xueyan Zhou, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 42
Transitional dendritic cells are distinct from conventional DC2 precursors and mediate proinflammatory antiviral responses
Fernando Bandeira Sulczewski, Raúl Antonio Maqueda‐Alfaro, Marcela Alcántara‐Hernández, et al.
Nature Immunology (2023) Vol. 24, Iss. 8, pp. 1265-1280
Closed Access | Times Cited: 32
Fernando Bandeira Sulczewski, Raúl Antonio Maqueda‐Alfaro, Marcela Alcántara‐Hernández, et al.
Nature Immunology (2023) Vol. 24, Iss. 8, pp. 1265-1280
Closed Access | Times Cited: 32
COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association, Therapeutic Options and Challenges
Saikat Dewanjee, Ramesh Kandimalla, Rajkumar Singh Kalra, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3291-3291
Open Access | Times Cited: 54
Saikat Dewanjee, Ramesh Kandimalla, Rajkumar Singh Kalra, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3291-3291
Open Access | Times Cited: 54
Deciphering the IgG Idiotype Network Through Proteomic Analysis of Potential Targets in SARS ‐CoV ‐2‐Induced Immune Responses
Nicolle Rakanidis Machado, Beatriz Oliveira Fagundes, Lais Alves do Nascimento, et al.
Immunology (2025)
Closed Access
Nicolle Rakanidis Machado, Beatriz Oliveira Fagundes, Lais Alves do Nascimento, et al.
Immunology (2025)
Closed Access
COVID-19 inflammation and implications in drug delivery
Makhloufi Zoulikha, Feifei Huang, Zhenfeng Wu, et al.
Journal of Controlled Release (2022) Vol. 346, pp. 260-274
Open Access | Times Cited: 23
Makhloufi Zoulikha, Feifei Huang, Zhenfeng Wu, et al.
Journal of Controlled Release (2022) Vol. 346, pp. 260-274
Open Access | Times Cited: 23
An Update on SARS-CoV-2 Clinical Trial Results—What We Can Learn for the Next Pandemic
Edi Dharmana, Juliane Brun, Michelle L. Hill, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 354-354
Open Access | Times Cited: 8
Edi Dharmana, Juliane Brun, Michelle L. Hill, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 354-354
Open Access | Times Cited: 8
Clinical efficacy and safety of interleukin-1 blockade in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
Shao‐Huan Lan, Chi‐Kuei Hsu, Shen-Peng Chang, et al.
Annals of Medicine (2023) Vol. 55, Iss. 1
Open Access | Times Cited: 7
Shao‐Huan Lan, Chi‐Kuei Hsu, Shen-Peng Chang, et al.
Annals of Medicine (2023) Vol. 55, Iss. 1
Open Access | Times Cited: 7
Advances in attractive therapeutic approach for macrophage activation syndrome in COVID-19
Shunyao Chen, Cong Zhang, Deng Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Shunyao Chen, Cong Zhang, Deng Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection
Muhammad Latif, Sudhanshu Shukla, Perla M. Del Río Estrada, et al.
Translational research (2021) Vol. 241, pp. 83-95
Open Access | Times Cited: 16
Muhammad Latif, Sudhanshu Shukla, Perla M. Del Río Estrada, et al.
Translational research (2021) Vol. 241, pp. 83-95
Open Access | Times Cited: 16
Immunouniverse of SARS-CoV-2
Dennis Jiménez, Marbel Torres Arias
Immunological Medicine (2022) Vol. 45, Iss. 4, pp. 186-224
Open Access | Times Cited: 11
Dennis Jiménez, Marbel Torres Arias
Immunological Medicine (2022) Vol. 45, Iss. 4, pp. 186-224
Open Access | Times Cited: 11
Pharmacological therapies and drug development targeting SARS-CoV-2 infection
Yi‐Zhou Jiang, Limor Rubin, Zhiwei Zhou, et al.
Cytokine & Growth Factor Reviews (2022) Vol. 68, pp. 13-24
Open Access | Times Cited: 10
Yi‐Zhou Jiang, Limor Rubin, Zhiwei Zhou, et al.
Cytokine & Growth Factor Reviews (2022) Vol. 68, pp. 13-24
Open Access | Times Cited: 10
Identifying potential novel insights for COVID-19 pathogenesis and therapeutics using an integrated bioinformatics analysis of host transcriptome
Salem A. El-aarag, Amal Mahmoud, Mahmoud ElHefnawi
International Journal of Biological Macromolecules (2021) Vol. 194, pp. 770-780
Open Access | Times Cited: 12
Salem A. El-aarag, Amal Mahmoud, Mahmoud ElHefnawi
International Journal of Biological Macromolecules (2021) Vol. 194, pp. 770-780
Open Access | Times Cited: 12
COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging association, therapeutic options, and challenges
Ramesh Kandimalla, Saikat Dewanjee, Rajkumar Singh Kalra, et al.
(2021)
Open Access | Times Cited: 12
Ramesh Kandimalla, Saikat Dewanjee, Rajkumar Singh Kalra, et al.
(2021)
Open Access | Times Cited: 12
Immunity and Coagulation in COVID-19
П. П. Авдонин, Maria S. Blinova, Anastasia A. Serkova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11267-11267
Open Access | Times Cited: 1
П. П. Авдонин, Maria S. Blinova, Anastasia A. Serkova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11267-11267
Open Access | Times Cited: 1
5‐Fluoro/(trifluoromethoxy)‐2‐indolinone derivatives with anti‐interleukin‐1 activity
Özge Soylu‐Eter, Zekiye Şeyma Sevinçli, Betül Ersoy, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 12
Open Access | Times Cited: 3
Özge Soylu‐Eter, Zekiye Şeyma Sevinçli, Betül Ersoy, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 12
Open Access | Times Cited: 3
Adult Still's disease: New horizons
Е. Л. Насонов, Eugen Feist
Rheumatology Science and Practice (2021) Vol. 59, Iss. 6, pp. 645-665
Open Access | Times Cited: 8
Е. Л. Насонов, Eugen Feist
Rheumatology Science and Practice (2021) Vol. 59, Iss. 6, pp. 645-665
Open Access | Times Cited: 8
Immunomonitoring of Monocyte and Neutrophil Function in Critically Ill Patients: From Sepsis and/or Trauma to COVID-19
Ivo Udovičić, Ivan Stanojević, Dragan Djordjević, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 24, pp. 5815-5815
Open Access | Times Cited: 8
Ivo Udovičić, Ivan Stanojević, Dragan Djordjević, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 24, pp. 5815-5815
Open Access | Times Cited: 8
Prediction of Survival by IL-6 in a Randomized Placebo-Controlled Trial of Anakinra in COVID-19 Cytokine Storm
Lesley E. Jackson, Nitasha Khullar, Timothy Beukelman, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 2036-2036
Open Access | Times Cited: 2
Lesley E. Jackson, Nitasha Khullar, Timothy Beukelman, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 2036-2036
Open Access | Times Cited: 2
The SARS-CoV-2 Nucleoprotein Induces Innate Memory in Human Monocytes
Patricia Urbán, Paola Italiani, Diana Boraschi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 4
Patricia Urbán, Paola Italiani, Diana Boraschi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 4
Omics-based Analysis of Bhadradarvadi Kashayam in Managing Rheumatoid Arthritis via CXCL8-CXCR1/2 axis, MAPK and NF-κB Signaling Pathways - A Network Pharmacology Approach
A. M. Mohamed Thoufic Ali, Vino Sundararajan
Biomedical & Pharmacology Journal (2024) Vol. 17, Iss. 2, pp. 1149-1164
Open Access
A. M. Mohamed Thoufic Ali, Vino Sundararajan
Biomedical & Pharmacology Journal (2024) Vol. 17, Iss. 2, pp. 1149-1164
Open Access
A Review of Potential Therapeutic Strategies for COVID-19
Jiajia Meng, Ruijiao Li, Zhiqi Zhang, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2346-2346
Open Access | Times Cited: 3
Jiajia Meng, Ruijiao Li, Zhiqi Zhang, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2346-2346
Open Access | Times Cited: 3
Adipose tissue-derived mesenchymal stromal cells attenuate acute lung injury induced by trauma and haemorrhagic shock
Zhi Zhang, Xiaoxia Yang, Meng Qing-hong, et al.
Immunobiology (2023) Vol. 228, Iss. 6, pp. 152765-152765
Open Access | Times Cited: 1
Zhi Zhang, Xiaoxia Yang, Meng Qing-hong, et al.
Immunobiology (2023) Vol. 228, Iss. 6, pp. 152765-152765
Open Access | Times Cited: 1
IL-1-mediated inflammation in COVID-19
Preeti Jain, Baldeep Singh, Sadhna Aggarwal, et al.
Elsevier eBooks (2023), pp. 141-161
Closed Access
Preeti Jain, Baldeep Singh, Sadhna Aggarwal, et al.
Elsevier eBooks (2023), pp. 141-161
Closed Access
Treatment of the cytokine storm in COVID-19: review of clinical pharmacology
Aisyah Nur Sapriati, Fita Rahmawati, Titik Nuryastuti
Jurnal Sains Farmasi & Klinis (2023) Vol. 10, Iss. 2, pp. 162-162
Open Access
Aisyah Nur Sapriati, Fita Rahmawati, Titik Nuryastuti
Jurnal Sains Farmasi & Klinis (2023) Vol. 10, Iss. 2, pp. 162-162
Open Access
